Advanced Cell Technology, Inc. Stock OTC Bulletin Board

Stocks

End-of-day quote OTC Bulletin Board
- ^USD	-

11/02/16	Ocata Therapeutics : Astellas Announces Results of Tender Offer to Acquire All Outstanding Shares of Ocata Therapeutics and Changes to Subsidiaries	PR
23/01/16	Ocata Therapeutics : Astellas Extends Tender Offer to Acquire All Outstanding Shares of Ocata Therapeutics	PR
29/12/15	Ocata Therapeutics : Reports the Publication of Data about the Generation of Corneal Endothelial Cells from Human Pluripotent Stem Cells	BU
04/12/15	Ocata Therapeutics : Hemangio-derived Mesenchymal Cells Preserve Kidney Function and Extend Lifespan in Preclinical Model of Lupus Nephritis	BU
12/11/15	OCATA THERAPEUTICS : Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Merger with Astellas Pharma Inc.	BU

Manager	Title	Age	Since
John Heffernan PRN	Corporate Officer/Principal	-	03/02/2015

Director	Title	Age	Since
Toru Yoshimitsu BRD	Director/Board Member	63	-
Masaaki Hirano BRD	Director/Board Member	59	-
Percival Barretto-Ko BRD	Director/Board Member	53	-

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
WUXI APPTEC CO., LTD.	+4.16%	+3.04%	+49.37%	+94.17%	74.41B
ARGENX SE	-1.07%	-1.51%	+24.46%	+78.24%	59.26B
LONZA GROUP AG	+0.68%	-0.42%	+4.50%	+34.79%	47.14B
IQVIA HOLDINGS INC.	-3.02%	-5.20%	+27.94%	+32.51%	42.91B
REVOLUTION MEDICINES, INC.	+0.31%	+3.02%	+348.95%	+643.82%	44.13B
BEONE MEDICINES AG	-1.96%	-0.33%	+7.04%	+99.46%	40.79B
CELLTRION, INC.	+3.32%	+3.49%	+10.10%	+51.23%	30.77B
WUXI BIOLOGICS (CAYMAN) INC.	-2.68%	+2.92%	+29.63%	+22.72%	29.31B
INSMED INCORPORATED	-4.86%	-10.66%	-26.27%	+330.06%	23.71B
Average	-0.57%	-0.52%	+52.86%	+154.11%	43.6B
Weighted average by Cap.	-0.03%	-0.32%	+58.04%	+145.80%

Employees

Sector